Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, CCA, CPG, CFG

/R E P E A T -- Notice to the media - Ministers and Government of Canada officials to hold a news conference on coronavirus disease (COVID-19)/


OTTAWA, March 25, 2020 /CNW/ - Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19).

Date
March 26, 2020

Time
12:00 PM (EDT)

Location

West Block, Room 225
Parliament Hill
Wellington Street, Ottawa, Ontario

The media availability will also be held by teleconference.
Toll-free (Canada/US) dial-in number: 1-866-206-0153
Passcode: 1622050#

Twitter: @GovCanHealth
Facebook: Healthy Canadians

SOURCE Public Health Agency of Canada


These press releases may also interest you

26 avr 2024
Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
Greenberg Traurig's David Dykeman and Roman Fayerberg to Present at DeviceTalks Boston
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance Provides Notice Following Data Security Incident
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

More news about Health...


News published on and distributed by: